IMIDomics Appoints Matthias Evers To Board Of Directors
18 Sep 2024 //
BUSINESSWIRE
IMIDomics and Bristol Myers Squibb Expand Long-Standing Partnership
06 Dec 2023 //
BUSINESSWIRE
IMIDomics Appointed Dr. Eric Perakslis to its Executive Team
15 Nov 2023 //
BUSINESSWIRE
IMIDomics Establishes Collaboration Partnership with the University of Barcelona
11 Oct 2023 //
BUSINESSWIRE
IMIDomics Announces Strategic Agreement with WuXi Biologics
04 Oct 2023 //
BUSINESSWIRE
IMIDomics Secures Worldwide Licensing Agreement with TNAX for TNAX101A
06 Sep 2023 //
BUSINESSWIRE
IMIDomics Announces Appointment of Medical Research Experts to Advisory Board
07 Dec 2022 //
BUSINESSWIRE
IMIDomics Announces Strategic Investment from Evotec SE
15 Feb 2022 //
BUSINESSWIRE